Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Immunoglobulin G FC (IgG FC), Low Endotoxin Level

Product Sizes
1 mg
16-16-090707-FC--LEL-1MG
10 mg
16-16-090707-FC--LEL-10MG
About this Product
SKU:
16-16-090707-FC--LEL
Additional Names:
Flow Cytometry, ELISA, Antisera Production, In Vitro Diagnostics, Proteomics, Cell Based Assays, Animal Studies|IgG FC, Fc stands for "Fragment Constant region" or "Fragment Crystallizable region." The names are essentially interchangable.
Application:
Cell-based/Functional Assay, ELISA, Flow Cytometry
Buffer:
Frozen in 50 mM Tris-HCl, pH 8.0, with 200 mM NaCl and 0.05% NaN3.
CE/IVD:
RUO
Extra Details:
The Fc (fragment crystallizable) region of immunoglobulin G, while not binding antigen, contains crucial biological activities and antigenic determinants. This homodimeric glycoprotein comprises CH2 and CH3 domains and mediates immune effector functions through interactions with Fc receptors, C1q, and FcRn. Fc fragments orchestrate antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, and phagocytosis while controlling IgG's serum half-life via pH-dependent FcRn binding. The conserved N-linked glycosylation at Asn-297 is essential for structural stability and receptor interactions. Altered Fc glycosylation patterns correlate with autoimmune conditions including rheumatoid arthritis, where reduced galactosylation and sialylation indicate inflammatory disease states. Fc receptor polymorphisms are also associated with autoimmune disease development.
Formulation:
Frozen in 50 mM Tris-HCl, pH 8.0, with 200 mM NaCl and 0.05% NaN3.
Molecular Weight:
50,000 Da
Physical State:
Frozen
Purity:
≥95%
Purification:
Liquid Chromatography Methods
Shipping Conditions:
Dry Ice
Source:
Source human plasma non-reactive for HBsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.
Storage Conditions:
Please refer to datasheet
Supplier:
Athens Research & Technology Inc.
Type:
Antibody: Isotype Controls